- Home
- /
- News
- /
- Biotherapeutics
- /
- September 2010
Biotherapeutics News for September 2010
The combined effects of numerous single-letter changes in several genes could be used to predict a woman’s risk of developing the most common form of breast cancer – oestrogen-receptor-positive breast cancer.
07 September, 2010
MorphoSys AG has announced a new proprietary development program against novel infectious disease targets. As part of this initiative, MorphoSys has signed a license and collaboration agreement with UK-based Absynth Biologics.
03 September, 2010